Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

Transitioning from MDD to MDR for a Global Medical Device Leader

A global medical device company in Northern Germany faced a critical need to update its product documentation to comply with the new Medical Device Regulation (MDR), replacing the older Medical Device Directive (MDD). Recognizing the potential impact on product registrations, labeling, and post-market activities, they turned to Zamann Pharma Support for assistance. The project involved evaluating all existing technical documentation and formulating an action plan to align those documents with MDR standards.

Zamann Pharma Support not only provided organizational guidance but also delivered hands-on support by completing the required document updates. This end-to-end approach ensured a smoother transition for the client’s product portfolio, helping the company maintain compliance and avoid regulatory setbacks.

Challenges Faced

A detailed GAP analysis in Quality Management Systems is essential for identifying process deficiencies effectively.
  • Complex Regulatory Shift: Moving from MDD to MDR entailed a range of new requirements, including expanded safety data, stricter clinical evidence, and enhanced post-market surveillance obligations. Many of these changes demanded detailed documentation updates.
  • High Volume of Products: The client owned numerous product lines with technical documentation at different levels of completion. Assessing and updating this extensive portfolio required significant coordination and resource planning.
  • Tight Timelines: Regulatory deadlines for MDR were looming, forcing the client to manage both day-to-day operations and an extensive documentation overhaul. Delays could lead to temporary or permanent suspension of product sales in critical markets.
  • Resource Constraints: The company’s internal regulatory teams were already stretched thin, making it difficult to handle a large-scale compliance update without external assistance.

Zamann Pharma Support’s Approach

  • Action Plan Development: We collaborated with the client’s expert teams to identify gaps in current technical documentation. Together, we mapped out a comprehensive plan prioritizing which products and documents required immediate attention.
  • Hands-On Documentation Updates: Rather than leaving updates solely to the client, Zamann took direct responsibility for rewriting, reorganizing, and supplementing documents as needed. This included revising design and risk assessments, clinical evaluation reports, post-market surveillance plans, and labeling elements to meet MDR guidelines.
  • Cross-Functional Collaboration: Our team worked closely with regulatory affairs, engineering, quality assurance, and clinical teams. This ongoing dialogue ensured that updates were accurate, consistent, and integrated into other areas of the organization’s quality system.
  • Continuous Monitoring: As regulations evolve and additional guidance emerges, Zamann provided periodic check-ins and real-time updates. This proactive stance helped ensure that the client could address new requirements swiftly and effectively.

Results Achieved

  • Regulatory Readiness: By completing critical document updates on schedule, the company maintained uninterrupted market access for its product lines.
  • Improved Documentation Quality: The revised and consolidated technical documentation now conforms to MDR standards, reducing the risk of compliance audits or negative inspection findings.
  • Efficient Use of Resources: Engaging Zamann freed the client’s internal teams to focus on other strategic initiatives. Our hands-on approach minimized duplication of efforts and facilitated a streamlined workflow.
  • Long-Term Compliance Strategy: Beyond immediate updates, the newly structured documentation lays a foundation for ongoing compliance under MDR, ensuring adaptability to future regulatory changes.
Laboratory
Regulatory team preparing technical documentation for medical device and IVD EU registration aligned with MDR and IVDR requirements
Services

Medical Devices & IVDs EU Registration

We guide companies through medical device and IVD EU registration by supporting MDR and IVDR requirements, technical documentation, and structured processes for compliant market access.

Read More

Contact Us

Need help? Don't hesitate to get in touch
Zamann pharma support is committed to protecting and respecting your privacy, and we’ll use your personal information to administer your account and to provide the products and services you requested from us.

FAQ

1. How can manufacturers manage the transition from MDD to MDR without risking product suspension?

Companies start by performing a structured gap analysis across all technical documentation. Then, they prioritize high-risk products and update critical files first. As a result, they maintain market access while systematically meeting MDR requirements.

2. What is the most effective way to update large volumes of technical documentation for MDR compliance?

Organizations divide documentation into prioritized groups and update them in parallel workflows. In addition, they revise key elements such as risk management, clinical evaluation, and post-market surveillance together. Therefore, they reduce delays and ensure consistent MDR alignment across the entire product portfolio.

3. How does external regulatory support improve MDR readiness for complex medical device portfolios?

External experts provide hands-on document updates and cross-functional coordination between QA, regulatory, and engineering teams. Moreover, they continuously monitor regulatory changes and integrate them into the documentation strategy. Consequently, companies achieve faster MDR readiness and reduce compliance risk during audits.